is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Menarini Group, The required for business and competitor intelligence needs
A study of the major internal and external factors affecting Menarini Group, The in the form of a SWOT analysis
An in-depth view of the business model of Menarini Group, The including a breakdown and examination of key business segments
Intelligence on Menarini Group, The’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Menarini Group, The, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
The Menarini Group (Menarini or 'the group'), a privately-held pharmaceutical business entity, is engaged in the development and manufacture of pharmaceutical products mainly for cardiovascular diseases; oncology; pain; inflammation; and asthma. The group primarily operates in Italy. It is headquartered in Florence, Italy and employed 16,457 people at the end of the year 2014.
Reasons to Purchase:
Gain understanding of Menarini Group, The and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Menarini Group, The as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Menarini Group, The’s business structure, strategy and prospects